BioCentury | Jul 18, 2020
Management Tracks

Genzyme vet Modur joins Zikani; plus Scholar Rock, Poseida, Ribon, Kiadis and more

...Greenstein was SVP of finance and corporate controller at Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) Microbiome company MaaT Pharma S.A....
...Inc. (NASDAQ:LOGC). Robin Sawka, BioCentury Staff ViaCyte Inc. Ribon Therapeutics Inc. Innate Pharma S.A. Kiadis Pharma N.V. Zikani Therapeutics Inc. Tarsus Pharmaceuticals Inc. MaaT Pharma S.A. Neurogene Poseida...
BioCentury | May 30, 2020
Management Tracks

Schneyer named Acadia CBO; plus Hansa, MaaT, iOnctura, First Light, Oligomerix, Galecto and Hyloris

...Before joining the autoimmune company, he served Basilea Pharmaceutica Ltd. (SIX:BSLN) in the same role. MaaT Pharma S.A....
...global head of healthcare at Degroof Petercam Investment Bank. Robin Sawka, BioCentury Staff Acadia Pharmaceuticals Inc. Hansa Biopharma AB MaaT Pharma S.A. iOnctura...
BioCentury | Feb 6, 2020
Finance

Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec

...Microbiome company MaaT gets $20M series B Looking to expand its microbiome platform into oncology, MaaT Pharma S.A....
...building out its IP portfolio and establishing a laboratory. Elizabeth S. Eaton, Staff Writer Aimmune Therapeutics Inc. Vineti Inc. MaaT Pharma S.A. Ziopharm...
BioCentury | Sep 13, 2019
Company News

Management tracks: Orchard, Black Diamond, ALK-Abelló, Menarini, Imvax, Rallybio, Milestone, MaaT and more

...of corporate development. Hasija was CFO and CBO at Fulcrum Therapeutics Inc. (NASDAQ:FULC). Microbiome company MaaT Pharma...
...where she served as counsel. BC Staff Black Diamond Therapeutics Inc. Rallybio LLC Milestone Pharmaceuticals Inc. Gritstone Oncology Inc. I-Mab Biopharma Pfizer Inc. MaaT Pharma S.A. Celcuity...
BioCentury | Mar 15, 2019
Product Development

The microbiome universe in two maps

...19 are developing specific strains, with an aggregate of 36 products (see “Community Organizers” ). MaaT Pharma S.A....
...Biosciences Inc. (NASDAQ:EVLO), Cambridge, Mass. Ferring Pharmaceuticals A/S, Saint-Prex, Switzerland Genetic Analysis A/S, Sagheling, Norway MaaT Pharma S.A....
...Writer, Research & Analytics 4D Pharma plc AOBiome Therapeutics Inc. Enterome Bioscience S.A. Evelo Biosciences Inc. Ferring Pharmaceuticals A/S Genetic Analysis A/S MaaT Pharma S.A. Osel...
BioCentury | Mar 5, 2019
Financial News

First close for Seventure's new microbiome fund

...companies, mostly in Europe, including Enterome Bioscience S.A. (Paris, France); Vedanta Biosciences Inc. (Cambridge, Mass.); MaaT Pharma S.A....
BioCentury | Mar 1, 2019
Product R&D

Mapping microbiome manufacturing

...Ph III June 2019 Finch Therapeutics Group Inc. CP101 Recurrent CDI Ph II July 2019 MaaT Pharma S.A....
BioCentury | Jan 11, 2019
Clinical News

MaaT's therapeutic restores functional microbiome in AML patients

...were presented in December at the American Society of Hematology (ASH) meeting in San Diego. MaaT Pharma S.A....
...measured by functional microbiota restoration Status: Phase Ib/IIa data Milestone: NA Elizabeth S. Eaton American Society of Hematology ASH MaaT Pharma S.A. Acute...
BioCentury | Aug 11, 2017
Clinical News

MaaT completes enrollment in Phase Ib of MaaT001 for dysbiosis

...the intestinal microbiota 10 days after FMT. Data from the trial are expected next quarter. MaaT Pharma S.A....
...autologous fecal microbiota transfer (FMT) Status: Completed Phase Ib enrollment Milestone: Phase Ib data (4Q17) Alicia Parker MaaT001 MaaT Pharma S.A....
BioCentury | Dec 1, 2016
Clinical News

Autologous fecal microbiota transplantation: Ph Ib ongoing

...microbiota transplantation in about 35 patients with acute myelogenous leukemia (AML) undergoing intensive induction chemotherapy. MaaT Pharma S.A....
...diversity and eradication of multidrug-resistant bacteria Status: Phase Ib ongoing Milestone: NA Alicia Parker autologous fecal microbiota transplantation MaaT Pharma S.A....
Items per page:
1 - 10 of 15
BioCentury | Jul 18, 2020
Management Tracks

Genzyme vet Modur joins Zikani; plus Scholar Rock, Poseida, Ribon, Kiadis and more

...Greenstein was SVP of finance and corporate controller at Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) Microbiome company MaaT Pharma S.A....
...Inc. (NASDAQ:LOGC). Robin Sawka, BioCentury Staff ViaCyte Inc. Ribon Therapeutics Inc. Innate Pharma S.A. Kiadis Pharma N.V. Zikani Therapeutics Inc. Tarsus Pharmaceuticals Inc. MaaT Pharma S.A. Neurogene Poseida...
BioCentury | May 30, 2020
Management Tracks

Schneyer named Acadia CBO; plus Hansa, MaaT, iOnctura, First Light, Oligomerix, Galecto and Hyloris

...Before joining the autoimmune company, he served Basilea Pharmaceutica Ltd. (SIX:BSLN) in the same role. MaaT Pharma S.A....
...global head of healthcare at Degroof Petercam Investment Bank. Robin Sawka, BioCentury Staff Acadia Pharmaceuticals Inc. Hansa Biopharma AB MaaT Pharma S.A. iOnctura...
BioCentury | Feb 6, 2020
Finance

Feb. 5 Financial Quick Takes: Aimmune gets $200M Nestlé investment; plus Vineti, MaaT, Kezar, Ziopharm, Ikarovec

...Microbiome company MaaT gets $20M series B Looking to expand its microbiome platform into oncology, MaaT Pharma S.A....
...building out its IP portfolio and establishing a laboratory. Elizabeth S. Eaton, Staff Writer Aimmune Therapeutics Inc. Vineti Inc. MaaT Pharma S.A. Ziopharm...
BioCentury | Sep 13, 2019
Company News

Management tracks: Orchard, Black Diamond, ALK-Abelló, Menarini, Imvax, Rallybio, Milestone, MaaT and more

...of corporate development. Hasija was CFO and CBO at Fulcrum Therapeutics Inc. (NASDAQ:FULC). Microbiome company MaaT Pharma...
...where she served as counsel. BC Staff Black Diamond Therapeutics Inc. Rallybio LLC Milestone Pharmaceuticals Inc. Gritstone Oncology Inc. I-Mab Biopharma Pfizer Inc. MaaT Pharma S.A. Celcuity...
BioCentury | Mar 15, 2019
Product Development

The microbiome universe in two maps

...19 are developing specific strains, with an aggregate of 36 products (see “Community Organizers” ). MaaT Pharma S.A....
...Biosciences Inc. (NASDAQ:EVLO), Cambridge, Mass. Ferring Pharmaceuticals A/S, Saint-Prex, Switzerland Genetic Analysis A/S, Sagheling, Norway MaaT Pharma S.A....
...Writer, Research & Analytics 4D Pharma plc AOBiome Therapeutics Inc. Enterome Bioscience S.A. Evelo Biosciences Inc. Ferring Pharmaceuticals A/S Genetic Analysis A/S MaaT Pharma S.A. Osel...
BioCentury | Mar 5, 2019
Financial News

First close for Seventure's new microbiome fund

...companies, mostly in Europe, including Enterome Bioscience S.A. (Paris, France); Vedanta Biosciences Inc. (Cambridge, Mass.); MaaT Pharma S.A....
BioCentury | Mar 1, 2019
Product R&D

Mapping microbiome manufacturing

...Ph III June 2019 Finch Therapeutics Group Inc. CP101 Recurrent CDI Ph II July 2019 MaaT Pharma S.A....
BioCentury | Jan 11, 2019
Clinical News

MaaT's therapeutic restores functional microbiome in AML patients

...were presented in December at the American Society of Hematology (ASH) meeting in San Diego. MaaT Pharma S.A....
...measured by functional microbiota restoration Status: Phase Ib/IIa data Milestone: NA Elizabeth S. Eaton American Society of Hematology ASH MaaT Pharma S.A. Acute...
BioCentury | Aug 11, 2017
Clinical News

MaaT completes enrollment in Phase Ib of MaaT001 for dysbiosis

...the intestinal microbiota 10 days after FMT. Data from the trial are expected next quarter. MaaT Pharma S.A....
...autologous fecal microbiota transfer (FMT) Status: Completed Phase Ib enrollment Milestone: Phase Ib data (4Q17) Alicia Parker MaaT001 MaaT Pharma S.A....
BioCentury | Dec 1, 2016
Clinical News

Autologous fecal microbiota transplantation: Ph Ib ongoing

...microbiota transplantation in about 35 patients with acute myelogenous leukemia (AML) undergoing intensive induction chemotherapy. MaaT Pharma S.A....
...diversity and eradication of multidrug-resistant bacteria Status: Phase Ib ongoing Milestone: NA Alicia Parker autologous fecal microbiota transplantation MaaT Pharma S.A....
Items per page:
1 - 10 of 15